PRIMARY CUTANEOUS MUCINOUS CARCINOMA

Clinical trials for PRIMARY CUTANEOUS MUCINOUS CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new PRIMARY CUTANEOUS MUCINOUS CARCINOMA trials appear

Sign up with your email to follow new studies for PRIMARY CUTANEOUS MUCINOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Virus + drug combo tested for Tough-to-Treat skin cancers

Disease control Ongoing

This study is testing a two-part treatment for patients with advanced skin cancers or rare lymphomas that have not responded to other therapies. First, a modified virus is injected directly into tumors to help the immune system recognize cancer. Then, an immunotherapy drug is giv…

Matched conditions: PRIMARY CUTANEOUS MUCINOUS CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

PRIMARY CUTANEOUS MUCINOUS CARCINOMA

Get alerted when new PRIMARY CUTANEOUS MUCINOUS CARCINOMA trials appear

Virus + drug combo tested for Tough-to-Treat skin cancers